Untoward effects of fluorescein retinal angiography in diabetic patients.
D000328:Adult; D000799:Angioedema / Q000139:chemically induced; D001784:Blood Gas Analysis; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D002707:Chlordiazepoxide / Q000494:pharmacology; D003228:Conjunctiva; D003930:Diabetic Retinopathy / Q000000981:diagnostic imaging*; D004562:Electrocardiography; D004569:Electroencephalography; D005451:Fluorescein Angiography / Q000009:adverse effects*; D005452:Fluoresceins / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009325:Nausea / Q000139:chemically induced / Q000628:therapy; D010102:Oxygen Inhalation Therapy; D011312:Pressure; D011859:Radiography; D012171:Retinal Vessels / Q000000981:diagnostic imaging*; D012912:Sneezing / Q000187:drug effects; D013546:Sweating / Q000187:drug effects; D013575:Syncope / Q000139:chemically induced
D001786:Blood Glucose; D005452:Fluoresceins; D002707:Chlordiazepoxide